+987.9%
MRNA vs SHAK
-21.2%
+1,009.2%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | SHAK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +3.8% | +9.3% | +11.8% |
| 7D | +20.6% | +8.3% | +12.3% | +17.4% |
| 30D | +27.1% | +16.7% | +10.5% | +19.9% |
| 3M | +353.4% | +10.0% | +343.4% | +345.5% |
| 6M | +446.3% | -23.8% | +470.1% | +460.0% |
| YTD | +776.2% | -10.3% | +786.4% | +747.3% |
| 1Y | +987.9% | -22.9% | +1,010.8% | +1,026.2% |
| All | +987.9% | -21.2% | +1,009.2% | +1,026.2% |
Cumulative growth
Daily Returns
Daily percentage return beside SHAK.
Daily Out/Under-Performance
Portfolio return minus SHAK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SHAK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded SHAK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling